With a strong R&D team with 100+ years of domain expertise and rich experience in injectables, we are an innovation oriented pharmaceutical organisation focused on delivering value expeditiously and efficiently. By combining their deep expertise in formulation and analytical development, our R&D is constantly engaged in providing unique and innovative solutions to deliver drugs to patients in the most efficient and cost-effective manner. With years of experience in the development, optimization, scale-up and transfer of lyophilization cycles for challenging formulations and product configurations; efficient manufacturing through cycle optimization is one of our key focus areas.
Bringing solutions to the fore in patient-friendly formats, we solve for the recurring shortages that plague hospitals and otherwise result in reliance on non-cGMP compliant solutions. Our efforts are focused on challenges that hospitals face in preparing the product before administration to a patient, thereby reducing medication misadventures, increasing convenience for the healthcare providers, reducing costs associated with wastage – all of which are conducive to providing higher quality patient care.
To supplement its own research capabilities, Steriscience continues to explore collaboration with other organizations to recognize co-development/partnership synergies. We are already partnered with leading R&D companies to take to market their differentiated product offerings that are synergistic to our strategy. We remain eager to collaborate with more partners to achieve our vision of enhancing patient care while leveraging our strong manufacturing capabilities.